Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin.

Abstract:

:Identification of cytotoxic T lymphocyte (CTL) epitopes from additional tumor antigens is essential for the development of specific immunotherapy of malignant tumors. Neuritin, a recently discovered antigen overexpressed in astrocytoma, is considered to be a promising target for biological therapy. In the present study, we predicted and identified HLA-A2-restricted CTL epitopes from neuritin by using the following four-step procedure: (1) computer-based epitope prediction from the amino acid sequence of neuritin; (2) peptide-binding assay to determine the affinity of the predicted peptide with HLA-A2.1 molecule; (3) stimulation of primary T cell response against the predicted peptides in vitro; and (4) testing of the induced CTLs toward target cells expressing neuritin and HLA-A2.1. The results demonstrated that effectors induced by peptides of neuritin containing residues 13-21, 121-129 and 4-12 could specifically-secrete interferon-γ and lyse target cells. Our results indicate that these peptides are new HLA-A2.1-restricted CTL epitopes, and may serve as valuable tools for astrocytoma immunotherapy.

journal_name

J Neurooncol

authors

Yang Z,Zhao T,Liu Y,Gong Z,Cheng S,Yang Q

doi

10.1007/s11060-013-1167-6

subject

Has Abstract

pub_date

2013-08-01 00:00:00

pages

51-8

issue

1

eissn

0167-594X

issn

1573-7373

journal_volume

114

pub_type

杂志文章
  • Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.

    abstract::Children with high-grade glioma (HGG) have a poor prognosis compared to those with low-grade glioma (LGG). Adjuvant chemotherapy may be beneficial, but its optimal use remains undetermined. Histology and extent of resection are important prognostic factors. We tested the hypothesis that patients with midline HGG treat...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s11060-014-1669-x

    authors: Eisenstat DD,Pollack IF,Demers A,Sapp MV,Lambert P,Weisfeld-Adams JD,Burger PC,Gilles F,Davis RL,Packer R,Boyett JM,Finlay JL

    更新日期:2015-02-01 00:00:00

  • C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.

    abstract::Ependymomas (EPN) show site specific genetic alterations and a recent DNA methylation profiling study identified nine molecular subgroups. C11orf95-RELA and YAP1 fusions characterise the RELA and YAP1 molecular subgroups, respectively, of supratentorial (ST)-EPNs. Current guidelines recommend molecular subgrouping ove...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-018-2767-y

    authors: Malgulwar PB,Nambirajan A,Pathak P,Faruq M,Rajeshwari M,Singh M,Suri V,Sarkar C,Sharma MC

    更新日期:2018-05-01 00:00:00

  • Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.

    abstract:AIM:To assess whether extent of surrounding edema correlates with acute adverse clinical outcomes within 3 months after stereotactic radiosurgery (SRS) for melanoma brain metastases (BM). METHODS:Patients with melanoma BM treated with SRS were included in a single center retrospective analysis. A contrast-enhanced mag...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-019-03330-9

    authors: Jardim A,Scott J,Drew Z,Foote MC,Sadasivan AP,Hall B,Olson SL,Shanker M,Pinkham MB

    更新日期:2019-12-01 00:00:00

  • Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation.

    abstract::Patients with locally advanced transitional cell carcinoma (TCC) of the bladder are at high risk for systemic relapse, with liver, bone and lung being the commonest sites of metastases. We report the case of a 52-year-old woman with a solitary meningeal relapse, a rare site of recurrence, after 8 months of complete re...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1005870408066

    authors: Santarossa S,Vaccher E,Balestreri L,Volpe R,Tirelli U

    更新日期:1997-11-01 00:00:00

  • Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.

    abstract::The Coronavirus pandemic has created unprecedented strain on medical resources at health care institutions around the world. At many institutions, this has resulted in efforts to prioritize cases with an attempt to balance the acuity of medical needs with available resources. Here, we provide a framework for instituti...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-020-03488-7

    authors: Ramakrishna R,Zadeh G,Sheehan JP,Aghi MK

    更新日期:2020-05-01 00:00:00

  • The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.

    abstract::This study assesses the controversial role of temozolomide (TMZ) concurrent with adjuvant radiation (RT) in patients with anaplastic astrocytoma (AA). The impact of isocitrate dehydrogenase (IDH) status on therapy and outcomes is also examined. All adult patients diagnosed with AA from 2001 to 2011 and treated with st...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-014-1520-4

    authors: Kizilbash SH,Giannini C,Voss JS,Decker PA,Jenkins RB,Hardie J,Laack NN,Parney IF,Uhm JH,Buckner JC

    更新日期:2014-10-01 00:00:00

  • Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors.

    abstract::This paper reviews the development of low-energy light ion accelerator-based neutron sources (ABNSs) for the treatment of brain tumors through an intact scalp and skull using boron neutron capture therapy (BNCT). A major advantage of an ABNS for BNCT over reactor-based neutron sources is the potential for siting withi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF02699931

    authors: Blue TE,Yanch JC

    更新日期:2003-03-01 00:00:00

  • Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study.

    abstract:BACKGROUND:Despite aspirations to achieve equality in healthcare we know that socioeconomic differences exist and may affect treatment and patient outcome, also in serious diseases such as cancer. We investigated disparities in neurosurgical care and outcome for patients with low-grade glioma (LGG). METHODS:In this na...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-019-03378-7

    authors: Carstam L,Rydén I,Gulati S,Rydenhag B,Henriksson R,Salvesen Ø,Smits A,Jakola AS

    更新日期:2020-01-01 00:00:00

  • Neurological dysfunction associated with postoperative cerebellar mutism.

    abstract:BACKGROUND AND OBJECTIVES:The postoperative cerebellar mutism syndrome (CMS) is an unique acute postoperative complication characterized by transient decrease in speech output (often mutism), apathy, irritability as well as global cerebellar dysfunction. As much as 25% of patients undergoing a resection of a cerebellar...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006483531811

    authors: Siffert J,Poussaint TY,Goumnerova LC,Scott RM,LaValley B,Tarbell NJ,Pomeroy SL

    更新日期:2000-05-01 00:00:00

  • Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma.

    abstract::To determine the impact of delay between surgery and radiotherapy on overall survival (OS) in temozolomide treatmented patients with the incorporation of O6-methylguanine-DNA methyltransferase (MGMT). From 2000 to 2012, 345 consecutive glioblastoma patients were treated with surgery, radiotherapy, and temozolomide at ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-013-1302-4

    authors: Spratt DE,Folkert M,Zumsteg ZS,Chan TA,Beal K,Gutin PH,Pentsova E,Yamada Y

    更新日期:2014-01-01 00:00:00

  • Spinal cord compression in prostate cancer.

    abstract::Approximately 200,000 men will be diagnosed with prostate cancer in 1994. While localized disease is potentially curable with surgery or radiation therapy, metastatic disease is incurable. The most frequent site of metastasis is bone. Spinal cord compression occurs in approximately 7% of men with prostate cancer. Back...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF01053418

    authors: Osborn JL,Getzenberg RH,Trump DL

    更新日期:1995-01-01 00:00:00

  • Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.

    abstract::Among diffuse gliomas, oligodendrogliomas may account for 25% of cases. They have a better prognosis and chemosensitivity as compared to astrocytomas. Genetic studies have shown a correlation between oligodendrocyte phenotype and presence of 1p/19q deletions. In addition, these deletions are of prognostic value. The a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/b:neon.0000027758.10286.c1

    authors: Bouvier C,Roll P,Quilichini B,Metellus P,Calisti A,Gilles S,Chinot O,Fina F,Martin PM,Figarella-Branger D

    更新日期:2004-06-01 00:00:00

  • Surgical resection for patients with benign primary brain tumors and low grade gliomas.

    abstract::'Benign' brain tumors are a heterogeneous group of primary neoplasms representing 40% of primary brain tumors. Amongst neuroepithelial tumors, astrocytic neoplasms predominate, followed by oligodendroglial and mixed glial and glial-neuronal neoplasms. Less common are tumors of the ependyma, choroid plexus and neuroepi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/b:neon.0000041871.46785.53

    authors: Piepmeier J,Baehring JM

    更新日期:2004-08-01 00:00:00

  • Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.

    abstract::Recurrent and progressive non-GBM gliomas are a diverse group of brain tumors that often respond poorly to adjuvant chemotherapy treatment. Regional intra-arterial (IA) administration of chemotherapy may result in increased tumor uptake of drug, with improvement in response rates and time to progression (TTP). Twenty-...

    journal_title:Journal of neuro-oncology

    pub_type: 临床试验,杂志文章

    doi:10.1023/a:1014498225405

    authors: Newton HB,Slivka MA,Stevens CL,Bourekas EC,Christoforidis GA,Baujan MA,Chakeres DW

    更新日期:2002-01-01 00:00:00

  • Neuropsychological sequelae of the treatment of children with medulloblastoma.

    abstract::When a malignant tumor invades the child's cerebellum, the cost of successful treatment is often significant cognitive morbidity. A review of neuropsychological outcome revealed that survivors of childhood medulloblastoma (MB) have long-term deficits in intelligence, memory, language, attention, academic skills, psych...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165522

    authors: Dennis M,Spiegler BJ,Hetherington CR,Greenberg ML

    更新日期:1996-07-01 00:00:00

  • Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.

    abstract:PURPOSE:Prediction of clinical outcomes in patients with primary central nervous system lymphoma (PCNSL) is important for optimization of treatment planning. Quantitative imaging biomarkers for PCNSL have not yet been established. This study evaluated the prognostic value of pretreatment dynamic contrast-enhanced MRI a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-018-2960-z

    authors: Hatzoglou V,Oh JH,Buck O,Lin X,Lee M,Shukla-Dave A,Young RJ,Peck KK,Vachha B,Holodny AI,Grommes C

    更新日期:2018-11-01 00:00:00

  • Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

    abstract::We have expressed the tumor suppressor p16 under the control of a tetracycline-sensitive promoter in two human glioblastoma cell lines which do not contain endogenous p16. Ectopic p16 expression led to a stable but reversible G1 phase cell cycle arrest, reduced the growth of both cell lines in cell culture, and almost...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1020226130478

    authors: Simon M,Simon C,Köster G,Hans VH,Schramm J

    更新日期:2002-10-01 00:00:00

  • Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.

    abstract::Human astrocytomas frequently co-express Fas (APO-1/CD95) and Fas ligand (FasL), yet do not appear to be overly susceptible to suicidal, fratricidal and immune-mediated elimination. This suggests that these gliomas have acquired mechanisms to prevent Fas-mediated apoptosis from occurring. Candidates for such a role in...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006311231189

    authors: Frankel B,Longo SL,Ryken TC

    更新日期:1999-01-01 00:00:00

  • High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression.

    abstract::Twenty-eight consecutive patients were given high-dose dexamethasone (96 mg i.v. loading dose, decreasing doses to zero in 14 days) and radiotherapy for epidural spinal cord compression due to malignant disease. There were eight events classified as side effects of the dexamethasone treatment. Four of these were consi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00172664

    authors: Heimdal K,Hirschberg H,Slettebø H,Watne K,Nome O

    更新日期:1992-02-01 00:00:00

  • Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas.

    abstract::The cell-penetrating trans-activator of transcription (TAT) is a cationic peptide derived from human immunodeficiency virus-1. It has been used to facilitate macromolecule delivery to various cell types. This cationic peptide is capable of crossing the blood-brain barrier and therefore might be useful for enhancing th...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2429-5

    authors: Nguyen J,Hossain SS,Cooke JRN,Ellis JA,Deci MB,Emala CW,Bruce JN,Bigio IJ,Straubinger RM,Joshi S

    更新日期:2017-05-01 00:00:00

  • Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.

    abstract::Gliomas, the most common malignant primary brain tumors, are universally fatal once they progress from low-grade into high-grade neoplasms. In recent years, we have accumulated unprecedented data about the genetic and epigenetic abnormalities in gliomas; yet, our appreciation of how these deadly tumors arise is still ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-014-1499-x

    authors: Tsankova NM,Canoll P

    更新日期:2014-09-01 00:00:00

  • Review of cranial radiotherapy-induced vasculopathy.

    abstract::Cranial radiation can impact the cerebral vasculature in many ways, with a wide range of clinical manifestations. The incidence of these late effects including cerebrovascular accidents (CVAs), lacunar lesions, vascular occlusive disease including moyamoya syndrome, vascular malformations, and hemorrhage is not well k...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-015-1732-2

    authors: Murphy ES,Xie H,Merchant TE,Yu JS,Chao ST,Suh JH

    更新日期:2015-05-01 00:00:00

  • Drug resistance and apoptosis in ENU-induced rat brain tumors treated with anti-cancer drugs.

    abstract::To cast light on the mechanisms of drug-resistance, experimental brain tumors were immunohistochemically evaluated for expression of glutathione S-transferase (GST)-alpha, mu, pi, p-glycoprotein and apoptosis-related factors, such as bcl-2 and p53, as well as by the terminal deoxynucleotidyl transferase-mediated dUTP-...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1005878402133

    authors: Yabuno T,Konishi N,Nakamura M,Tsuzuki T,Tsunoda S,Sakaki T,Hiasa Y

    更新日期:1998-01-01 00:00:00

  • Vascular malformations of the thalamus with normal angiograms.

    abstract::We describe two patients with fatal vascular malformations of the thalamus whom we thought had gliomas. They had progressive neurological impairment with subacute onset as adults. Computed tomography showed lesions of increased density with slight post-contrast enhancement; cerebral angiography was normal. Without bio...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165174

    authors: Norcross K,Ciric IS,Mikhael MA,Vick NA

    更新日期:1985-01-01 00:00:00

  • Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.

    abstract::Immune checkpoint inhibitors have demonstrated remarkable benefits in cancer patients. However, concern regarding toxicity in the setting of stereotactic radiosurgery (SRS) is often raised. In this study, we characterize radiation necrosis (RN) following immunotherapy and SRS. Melanoma patients treated with SRS and an...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2470-4

    authors: Fang P,Jiang W,Allen P,Glitza I,Guha N,Hwu P,Ghia A,Phan J,Mahajan A,Tawbi H,Li J

    更新日期:2017-07-01 00:00:00

  • Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation.

    abstract::Ceramide is a physiologic regulator of growth and differentiation in mammalian cells. In this study, the relationship between ceramide and FLICE inhibitory protein (FLIP) in the induction of apoptosis in glioblastoma cell lines was investigated. We found that LN215 cells were slightly more sensitive to Fas-mediated ap...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1020604705831

    authors: Yoon G,Kim KO,Lee J,Kwon D,Shin JS,Kim SJ,Choi IH

    更新日期:2002-11-01 00:00:00

  • Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.

    abstract:OBJECT:Although atypical teratoid/rhabdoid tumor (AT/RT) is known to generate through inactivation of the hSNF5/INI1 gene on chromosome 22q, the downstream molecular mechanism remains unclear. We histologically and molecularly reviewed our pediatric brain tumors for unrecognized AT/RTs and evaluated the role of cyclin ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-004-4276-4

    authors: Fujisawa H,Misaki K,Takabatake Y,Hasegawa M,Yamashita J

    更新日期:2005-06-01 00:00:00

  • Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients.

    abstract::Thirty-five adult recurrent GBM patients, divided randomly in two groups of 19 and 16 cases, had been treated with two regimens of chemotherapy: a) 'eight-drugs-in-one-day'; b) procarbazine + CCNU + vincristine (PCV) respectively. Chemotherapy was planned at the tumour relapse and delivered as long as tolerated withou...

    journal_title:Journal of neuro-oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00172666

    authors: Boiardi A,Silvani A,Milanesi I,Broggi G,Fariselli L

    更新日期:1992-02-01 00:00:00

  • Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

    abstract::Pediatric brain gliomas are not always amenable for complete surgical excision, therefore adjuvant treatment for a large tumor mass is often required. As tumor volume shrinkage may not be a reliable method for assessing response to treatment, information about the tumor growth potential is desirable for an adequate fo...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006120623949

    authors: Lazareff JA,Gupta RK,Alger J

    更新日期:1999-02-01 00:00:00

  • MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.

    abstract::Glioblastoma (GBM) is among the most aggressive primary brain tumors, with a median survival rate of 12-15 months. MicroRNAs have been implicated in GBM development as oncogenes or tumor suppressors. In this study, we demonstrated that miR-519a expression was frequently downregulated in GBM specimens and cell lines, a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-016-2095-z

    authors: Hong L,Ya-Wei L,Hai W,Qiang Z,Jun-Jie L,Huang A,Song-Tao Q,Yun-Tao L

    更新日期:2016-05-01 00:00:00